Dentsply Sirona reported second-quarter 2026 results showing a 4.1% year-over-year net sales decline but a return to net income, with higher margins and stronger cash generation, and confirmed it will present at the Baird 2026 Global Healthcare Conference on September 15, 2026. Management reiterated full-year 2026 guidance of US$3.5 billion to US$3.6 billion in net sales and adjusted EPS of US$1.40 to US$1.50, despite the sales drop, highlighting a sharper focus on efficiency and margin quality. The company's narrative projects US$3.8 billion revenue and US$189.7 million earnings by 2029, requiring a US$817.7 million earnings increase from -US$628.0 million today, and yields a fair value of US$13.40, a 17% upside to its current price. However, cautious analysts assume roughly flat revenue near US$3.7 billion and only about US$73.7 million of earnings, sketching a far more constrained recovery path that this latest profit rebound might or might not meaningfully shift.
Microsoft Corporation
NVIDIA CorporationDentsply Sirona IncReaffirms 2026 guidance and reports Q2 profit recovery with higher margins and cash generation.
